Linklaters has advised Carlyle, the global investment firm, on its €250 million strategic investment in Sanoptis, a European leader in ophthalmology services.
The investment, which is through preferred equity, is expected to fund Sanoptis’ growth and expansion, including through strategic M&A, and investment in state-of-the-art technologies and treatments.
Majority-owned by investment company Groupe Bruxelles Lambert, Sanoptis has over 450 locations across Germany, Switzerland, Italy, Spain, Austria and Greece.
The Linklaters cross-practice team was led by Private Equity Partner Andrew Lynch and Managing Associate Tom Gavin, alongside Associates Nitesh Nagrath, Dulan Dantanarayana and Tanaya Rajwade.
They were supported by Leveraged Finance Partner Pathik Gandhi and Managing Associate Harshit Neotia, Tax Partner Alexei Franks and Managing Associate Anna Sparrow and Luxembourg Corporate M&A Partner Catherine Kremer, Counsel Florence Forster and Senior Managing Associate Aurélie Mounier.
